Your browser doesn't support javascript.
loading
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.
Shen, Chong; Li, Zhi; Zhang, Yinglang; Zhang, Zhe; Wu, Zhouliang; Da, La; Yang, Shaobo; Wang, Zejin; Zhang, Yu; Qie, Yunkai; Zhao, Gangjian; Lin, Yuda; Huang, Shiwang; Zhou, Mingli; Hu, Hailong.
Affiliation
  • Shen C; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Li Z; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Zhang Y; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Zhang Z; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Wu Z; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Da; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Yang S; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Wang Z; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Zhang Y; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Qie Y; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Zhao G; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Lin Y; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Huang S; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Zhou M; Tianjin Key Laboratory of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
  • Hu H; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.
Front Oncol ; 12: 1018285, 2022.
Article in En | MEDLINE | ID: mdl-36300085

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2022 Type: Article Affiliation country: China